{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:04:35Z","timestamp":1775595875546,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,9]]},"DOI":"10.7759\/cureus.43220","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T16:41:50Z","timestamp":1691599310000},"source":"Crossref","is-referenced-by-count":0,"title":["Is Cannabis Effective in the Treatment of Chronic Back Pain?"],"prefix":"10.7759","author":[{"given":"Josiah","family":"Damisa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Petohazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Jallil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120926677","article-title":"Medical cannabis in the UK: from principle to practice","volume":"34","author":"Schlag AK","year":"2020","unstructured":"Schlag AK, Baldwin DS, Barnes M, et al.. Medical cannabis in the UK: from principle to practice. J Psychopharmacol. 2020, 34:931-7. 10.1177\/0269881120926677","journal-title":"J Psychopharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2217\/pmt.14.49","article-title":"Re-branding cannabis: the next generation of chronic pain medicine?","volume":"5","author":"Carter GT","year":"2015","unstructured":"Carter GT, Javaher SP, Nguyen MH, Garret S, Carlini BH. Re-branding cannabis: the next generation of chronic pain medicine?. Pain Manag. 2015, 5:13-21. 10.2217\/pmt.14.49","journal-title":"Pain Manag"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1981.10471447","article-title":"The religious and medicinal uses of cannabis in China, India and Tibet","volume":"13","author":"Touw M","year":"1981","unstructured":"Touw M. The religious and medicinal uses of cannabis in China, India and Tibet. J Psychoactive Drugs. 1981, 13:23-34. 10.1080\/02791072.1981.10471447","journal-title":"J Psychoactive Drugs"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/ner.12018","article-title":"Epidemiology of low back pain in adults","volume":"17 Suppl 2","author":"Manchikanti L","year":"2014","unstructured":"Manchikanti L, Singh V, Falco FJ, Benyamin RM, Hirsch JA. Epidemiology of low back pain in adults. Neuromodulation. 2014, 17 Suppl 2:3-10. 10.1111\/ner.12018","journal-title":"Neuromodulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2013.03.018","article-title":"The epidemiology and impact of pain in osteoarthritis","volume":"21","author":"Neogi T","year":"2013","unstructured":"Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage. 2013, 21:1145-53. 10.1016\/j.joca.2013.03.018","journal-title":"Osteoarthritis Cartilage"},{"key":"ref6","unstructured":"National Institute for Health and Care Excellence. Cannabis-based medicinal products. (2019). https.\/\/www.nice.org.uk\/guidance\/ng144."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei183","article-title":"Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis","volume":"45","author":"Blake DR","year":"2006","unstructured":"Blake DR, Robson P, Ho M, Jubb RW, McCabe CS. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford). 2006, 45:50-2. 10.1093\/rheumatology\/kei183","journal-title":"Rheumatology (Oxford)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1048","article-title":"Cannabis and anxiety: a critical review of the evidence","volume":"24","author":"Crippa JA","year":"2009","unstructured":"Crippa JA, Zuardi AW, Mart\u00edn-Santos R, Bhattacharyya S, Atakan Z, McGuire P, Fusar-Poli P. Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol. 2009, 24:515-23. 10.1002\/hup.1048","journal-title":"Hum Psychopharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review","volume":"370","author":"Moore TH","year":"2007","unstructured":"Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007, 370:319-28. 10.1016\/S0140-6736(07)61162-3","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2217\/pmt-2018-0051","article-title":"Perspectives on cannabis as a substitute for opioid analgesics","volume":"9","author":"Khan SP","year":"2019","unstructured":"Khan SP, Pickens TA, Berlau DJ. Perspectives on cannabis as a substitute for opioid analgesics. Pain Manag. 2019, 9:191-203. 10.2217\/pmt-2018-0051","journal-title":"Pain Manag"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1089\/can.2017.0017","article-title":"Cannabis and pain: a clinical review","volume":"2","author":"Hill KP","year":"2017","unstructured":"Hill KP, Palastro MD, Johnson B, Ditre JW. Cannabis and pain: a clinical review. Cannabis Cannabinoid Res. 2017, 2:96-104. 10.1089\/can.2017.0017","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.51","article-title":"Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis","volume":"42","author":"Nielsen S","year":"2017","unstructured":"Nielsen S, Sabioni P, Trigo JM, et al.. Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis. Neuropsychopharmacology. 2017, 42:1752-65. 10.1038\/npp.2017.51","journal-title":"Neuropsychopharmacology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/nature03658","article-title":"An endocannabinoid mechanism for stress-induced analgesia","volume":"435","author":"Hohmann AG","year":"2005","unstructured":"Hohmann AG, Suplita RL, Bolton NM, et al.. An endocannabinoid mechanism for stress-induced analgesia. Nature. 2005, 435:1108-12. 10.1038\/nature03658","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409888102","article-title":"CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids","volume":"102","author":"Ibrahim MM","year":"2005","unstructured":"Ibrahim MM, Porreca F, Lai J, et al.. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci U S A. 2005, 102:3093-8. 10.1073\/pnas.0409888102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-020-00873-9","article-title":"The role of the cannabinoid system in pain control: basic and clinical implications","volume":"24","author":"Wolf J","year":"2020","unstructured":"Wolf J, Urits I, Orhurhu V, et al.. The role of the cannabinoid system in pain control: basic and clinical implications. Curr Pain Headache Rep. 2020, 24:35. 10.1007\/s11916-020-00873-9","journal-title":"Curr Pain Headache Rep"},{"key":"ref16","article-title":"Efficacy of cannabis-based medicines for pain management: a systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Aviram J","year":"2017","unstructured":"Aviram J, Samuelly-Leichtag G. Efficacy of cannabis-based medicines for pain management: a systematic review and meta-analysis of randomized controlled trials. Pain Physician. 2017, 20:E755-96.","journal-title":"Pain Physician"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1503\/cjs.001018","article-title":"Cannabis for pain in orthopedics: a systematic review focusing on study methodology","volume":"62","author":"Madden K","year":"2019","unstructured":"Madden K, George A, van der Hoek NJ, Borim FM, Mammen G, Bhandari M. Cannabis for pain in orthopedics: a systematic review focusing on study methodology. Can J Surg. 2019, 62:369-80. 10.1503\/cjs.001018","journal-title":"Can J Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnz168","article-title":"Cannabis for chronic pain: we simply don't know","volume":"21","author":"Nugent SM","year":"2020","unstructured":"Nugent SM, Kansagara D. Cannabis for chronic pain: we simply don't know. Pain Med. 2020, 21:1091-2. 10.1093\/pm\/pnz168","journal-title":"Pain Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24173031","article-title":"Terpenoids and phytocannabinoids co-produced in cannabis sativa strains show specific interaction for cell cytotoxic activity","volume":"24","author":"Namdar D","year":"2019","unstructured":"Namdar D, Voet H, Ajjampura V, et al.. Terpenoids and phytocannabinoids co-produced in cannabis sativa strains show specific interaction for cell cytotoxic activity. Molecules. 2019, 24:3031. 10.3390\/molecules24173031","journal-title":"Molecules"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011666","article-title":"Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999-2014","volume":"6","author":"Hatswell AJ","year":"2016","unstructured":"Hatswell AJ, Baio G, Berlin JA, Irs A, Freemantle N. Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999-2014. BMJ Open. 2016, 6:e011666. 10.1136\/bmjopen-2016-011666","journal-title":"BMJ Open"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038687","article-title":"So near yet so far: why won't the UK prescribe medical cannabis?","volume":"10","author":"Nutt D","year":"2020","unstructured":"Nutt D, Bazire S, Phillips LD, Schlag AK. So near yet so far: why won't the UK prescribe medical cannabis?. BMJ Open. 2020, 10:e038687. 10.1136\/bmjopen-2020-038687","journal-title":"BMJ Open"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2013.772618","article-title":"Probability and predictors of transition from abuse to dependence on alcohol, cannabis, and cocaine: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"39","author":"Fl\u00f3rez-Salamanca L","year":"2013","unstructured":"Fl\u00f3rez-Salamanca L, Secades-Villa R, Hasin DS, Cottler L, Wang S, Grant BF, Blanco C. Probability and predictors of transition from abuse to dependence on alcohol, cannabis, and cocaine: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Am J Drug Alcohol Abuse. 2013, 39:168-79. 10.3109\/00952990.2013.772618","journal-title":"Am J Drug Alcohol Abuse"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.11.004","article-title":"Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)","volume":"115","author":"Lopez-Quintero C","year":"2011","unstructured":"Lopez-Quintero C, P\u00e9rez de los Cobos J, Hasin DS, Okuda M, Wang S, Grant BF, Blanco C. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2011, 115:120-30. 10.1016\/j.drugalcdep.2010.11.004","journal-title":"Drug Alcohol Depend"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.11.1967","article-title":"Review of the validity and significance of cannabis withdrawal syndrome","volume":"161","author":"Budney AJ","year":"2004","unstructured":"Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004, 161:1967-77. 10.1176\/appi.ajp.161.11.1967","journal-title":"Am J Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.091414","article-title":"Smoked cannabis for chronic neuropathic pain: a randomized controlled trial","volume":"182","author":"Ware MA","year":"2010","unstructured":"Ware MA, Wang T, Shapiro S, et al.. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ. 2010, 182:E694-701. 10.1503\/cmaj.091414","journal-title":"CMAJ"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e536","article-title":"Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis","volume":"344","author":"Asbridge M","year":"2012","unstructured":"Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ. 2012, 344:e536. 10.1136\/bmj.e536","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.071178","article-title":"Adverse effects of medical cannabinoids: a systematic review","volume":"178","author":"Wang T","year":"2008","unstructured":"Wang T, Collet JP, Shapiro S, Ware MA. Adverse effects of medical cannabinoids: a systematic review. CMAJ. 2008, 178:1669-78. 10.1503\/cmaj.071178","journal-title":"CMAJ"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.10.008","article-title":"Prevalence and correlates of \"vaping\" as a route of cannabis administration in medical cannabis patients","volume":"169","author":"Cranford JA","year":"2016","unstructured":"Cranford JA, Bohnert KM, Perron BE, Bourque C, Ilgen M. Prevalence and correlates of \"vaping\" as a route of cannabis administration in medical cannabis patients. Drug Alcohol Depend. 2016, 169:41-7. 10.1016\/j.drugalcdep.2016.10.008","journal-title":"Drug Alcohol Depend"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical considerations in medical cannabis administration and dosing","volume":"49","author":"MacCallum CA","year":"2018","unstructured":"MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018, 49:12-9. 10.1016\/j.ejim.2018.01.004","journal-title":"Eur J Intern Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.03.019","article-title":"Non-smoker exposure to secondhand cannabis smoke II: effect of room ventilation on the physiological, subjective, and behavioral\/cognitive effects","volume":"151","author":"Herrmann ES","year":"2015","unstructured":"Herrmann ES, Cone EJ, Mitchell JM, Bigelow GE, LoDico C, Flegel R, Vandrey R. Non-smoker exposure to secondhand cannabis smoke II: effect of room ventilation on the physiological, subjective, and behavioral\/cognitive effects. Drug Alcohol Depend. 2015, 151:194-202. 10.1016\/j.drugalcdep.2015.03.019","journal-title":"Drug Alcohol Depend"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.01.016","article-title":"Ethical issues in medical cannabis use","volume":"49","author":"Sagy I","year":"2018","unstructured":"Sagy I, Peleg-Sagy T, Barski L, Zeller L, Jotkowitz A. Ethical issues in medical cannabis use. Eur J Intern Med. 2018, 49:20-2. 10.1016\/j.ejim.2018.01.016","journal-title":"Eur J Intern Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-eular.2511","article-title":"AB1133\u2005comparison of Canadian and Israeli rheumatologists' understanding of cannabinoid use as a therapy for rheumatic diseases","volume":"73","author":"Fitzcharles MA","year":"2014","unstructured":"Fitzcharles MA, Ste-Marie P, Ablin J, Shir Y. AB1133\u2005comparison of Canadian and Israeli rheumatologists' understanding of cannabinoid use as a therapy for rheumatic diseases. Ann Rheum Dis. 2014, 73:1177. 10.1136\/annrheumdis-2014-eular.2511","journal-title":"Ann Rheum Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.04.016","article-title":"Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003-11","volume":"140","author":"Schuermeyer J","year":"2014","unstructured":"Schuermeyer J, Salomonsen-Sautel S, Price RK, Balan S, Thurstone C, Min SJ, Sakai JT. Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003-11. Drug Alcohol Depend. 2014, 140:145-55. 10.1016\/j.drugalcdep.2014.04.016","journal-title":"Drug Alcohol Depend"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.4005","article-title":"Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010","volume":"174","author":"Bachhuber MA","year":"2014","unstructured":"Bachhuber MA, Saloner B, Cunningham CO, Barry CL. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med. 2014, 174:1668-73. 10.1001\/jamainternmed.2014.4005","journal-title":"JAMA Intern Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2015.1661","article-title":"Medical marijuana laws reduce prescription medication use in Medicare Part D","volume":"35","author":"Bradford AC","year":"2016","unstructured":"Bradford AC, Bradford WD. Medical marijuana laws reduce prescription medication use in Medicare Part D. Health Aff (Millwood). 2016, 35:1230-6. 10.1377\/hlthaff.2015.1661","journal-title":"Health Aff (Millwood)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/169307-is-cannabis-effective-in-the-treatment-of-chronic-back-pain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:11Z","timestamp":1707508931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/169307-is-cannabis-effective-in-the-treatment-of-chronic-back-pain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.43220","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,9]]}}}